Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01597089 · ClinicalTrials.gov registry record
Detecting Respiratory Viruses in Upper and Lower Respiratory Tract Samples
A clinical trial, sponsored by National Institutes of Health Clinical Center (CC).
- Terminated
- Registry status
- 35
- Enrollment target
NCT01597089 is a clinical trial that was terminated before completion, run by National Institutes of Health Clinical Center (CC). The registered enrollment target is 35 participants.
The verdict
NCT01597089 was terminated before completion, sponsored by National Institutes of Health Clinical Center (CC).
- TERMINATED
- Registry status
- 35 participants
- Enrollment target
Study Summary
Background: \- Bronchoalveolar lavage (BAL) is a procedure where a tube is passed through the mouth or nose into the lungs. Fluid is squirted through the tube into a part of the lung and then collected for examination. It is used to detect respiratory viruses. BAL is a relatively invasive procedure, and researchers want to test the accuracy of other procedures that do not involve collecting fluid from the lungs. The nasopharynx is the area of the upper throat that lies behind the nose. Researchers want to see if a swab taken from this area is as accurate as a BAL sample. Objectives: \- To see if a nasopharynx swab can be used to detect respiratory viruses as well as BAL samples. Eligibility: \- Individuals at least 12 years of age who will have a bronchoscopy to collect a BAL sample to test for respiratory viruses. Design: * Participants will be screened with a physical exam and medical history. * Participants will have a BAL sample collected. * Participants will then have a nasopharynx swab. The swab will be inserted into the nose, left in place for up to 10 seconds, and then removed
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2012-09-01 |
| Est. Completion | 2018-05-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01597089
The ClinicalTrials.gov registry entry for NCT01597089 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institutes of Health Clinical Center (CC), which has 338 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01597089 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01597089 about?
NCT01597089 is a clinical study titled "Detecting Respiratory Viruses in Upper and Lower Respiratory Tract Samples". Background: \- Bronchoalveolar lavage (BAL) is a procedure where a tube is passed through the mouth or nose into the lungs. Fluid is squirted through the tube into a part of the lung and then collected for examination. It is used to detect respiratory viruses. BAL is a relatively invasive procedure...
What is the current status of trial NCT01597089?
This trial is currently terminated. The enrollment target is 35 participants. The study started on 2012-09-01. Estimated completion is 2018-05-01.
Who is sponsoring clinical trial NCT01597089?
This trial is sponsored by National Institutes of Health Clinical Center (CC), which has 338 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.